Skip to main content
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery 1/2023

08.12.2022 | Original Article

Single Topical Application of 1% Clotrimazole Cream in Otomycosis

verfasst von: Reshma P. Chavan, Shivraj M. Ingole, Gajanan S. Kanchewad Resident

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Sonderheft 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Aim: To assess the clinical improvement after single dose topical application of 1% clotrimazole cream in otomycosis and follow up for recurrence at the end of first and the third month. Materials and Methods: A prospective observational study was carried out at Government Medical college hospital. Patients with KOH diagnosed fungal infection of external auditory canal were included in the study. After obtaining informed written consent from the participating patients, a detail clinical history was taken. Single topical application of 1% clotrimazole cream in otomycosis. The fungal debris was removed with the help of suction aspiration and dry mopping. A single topical application of 1% clotrimazole cream was applied under all aseptic precautions. On the 3rd day the applied cream was cleaned with help of suction under ear microscope. Patients were advised to follow up after one month and three months. During each follow up patients were assessed clinically and examined for residual fungal debris. Result: Otomycosis was seen predominantly in middle aged females, housewives and laborers by occupation. Earache was most common symptom seen in 65.2%. Unilateral involvement was seen in 89.3% cases. The most common organism isolated in otomycosis was Aspergillus niger. At the end of one month of treatment with a single dose of 1% clotrimazole cream, 102 (91.0%) patients were recovered and 10 (9.0%) patients were with persistence or recurrence of the symptoms. At the end of third month, the recovery rate was 84.8% and recurrence rate was 6.3%. Conclusion: Single topical application of 1% clotrimazole cream is effective in treating otomycosis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Gharaghani M, Seifi Z, Zarei Mahmoudabadi A (June 2015) Otomycosis in Iran: a review. Mycopathologia 179(5–6):415–424 Gharaghani M, Seifi Z, Zarei Mahmoudabadi A (June 2015) Otomycosis in Iran: a review. Mycopathologia 179(5–6):415–424
2.
Zurück zum Zitat Ho T, Vrabec JT, Yoo D, Cocker NJ, Nov (2006) Otomycosis: clinical features and treatment implications. Otolaryngol Head Neck Surg 135(5):787–791CrossRefPubMed Ho T, Vrabec JT, Yoo D, Cocker NJ, Nov (2006) Otomycosis: clinical features and treatment implications. Otolaryngol Head Neck Surg 135(5):787–791CrossRefPubMed
3.
Zurück zum Zitat Viswanatha B, Sumatha D, Vijayashree MS (Mar.2012) Otomycosis in immunocompetent and immunocompromised patients: comparative study and literature review.Ear Nose & Throat J91 (3):114–21 Viswanatha B, Sumatha D, Vijayashree MS (Mar.2012) Otomycosis in immunocompetent and immunocompromised patients: comparative study and literature review.Ear Nose & Throat J91 (3):114–21
4.
Zurück zum Zitat Vennewald I, Klemm E (Mar.2010)Otomycosis: diagnosis and treatment.Clinics in dermatology28(2):202–11 Vennewald I, Klemm E (Mar.2010)Otomycosis: diagnosis and treatment.Clinics in dermatology28(2):202–11
5.
Zurück zum Zitat Mahmoudabadi AZ (2006) Mycological Studies in 15 cases of otomycosis. Pakistan J Med Sci 22(4):486–488 Mahmoudabadi AZ (2006) Mycological Studies in 15 cases of otomycosis. Pakistan J Med Sci 22(4):486–488
6.
Zurück zum Zitat Değerli K, Ecemiş T, Günhan K, Başkesen T, Kal E (Jan.2012) Manisa Bölgesinde Otomikoz Etkenleri, Agents of otomycosis in Manisa region, Turkey, 1995–2011.Mikrobiyoloji bulteni46(1):79–84 Değerli K, Ecemiş T, Günhan K, Başkesen T, Kal E (Jan.2012) Manisa Bölgesinde Otomikoz Etkenleri, Agents of otomycosis in Manisa region, Turkey, 1995–2011.Mikrobiyoloji bulteni46(1):79–84
7.
Zurück zum Zitat Levitt JO, Levitt BH, Akhavan A, Yanofsky H (eds) (2010) The sensitivity and specitity of potassium hydroxide smear and fungal culture relative to clinical assessment in the evaluation of tinea pedis: a pooled analysis. Dermatology research and practice 22; 2010 Levitt JO, Levitt BH, Akhavan A, Yanofsky H (eds) (2010) The sensitivity and specitity of potassium hydroxide smear and fungal culture relative to clinical assessment in the evaluation of tinea pedis: a pooled analysis. Dermatology research and practice 22; 2010
8.
Zurück zum Zitat Rath S, Das SR, Pandhy RN (eds) (2019) Bayesian analysis of two methods MALDI-TOF-MS system and culture test in otomycosis infection. World Journal of Otorhinolaryngology-Head and Neck Surgery 1;5(1):6–13 Rath S, Das SR, Pandhy RN (eds) (2019) Bayesian analysis of two methods MALDI-TOF-MS system and culture test in otomycosis infection. World Journal of Otorhinolaryngology-Head and Neck Surgery 1;5(1):6–13
9.
Zurück zum Zitat Dundar R, İynen İ (2019) Single Dose Topical Application of Clotrimazole for the Treatment of Otomycosis: Is this Enough? J Audiol Otology 23(1):15–19CrossRef Dundar R, İynen İ (2019) Single Dose Topical Application of Clotrimazole for the Treatment of Otomycosis: Is this Enough? J Audiol Otology 23(1):15–19CrossRef
10.
Zurück zum Zitat Herasym K, Bonaparte JP, Kilty S (Jun.2016) A comparison of Locacorten-Vioform and clotrimazole in otomycosis: A systematic review and one-way meta-analysis.Laryngoscope126(6):1411–9 Herasym K, Bonaparte JP, Kilty S (Jun.2016) A comparison of Locacorten-Vioform and clotrimazole in otomycosis: A systematic review and one-way meta-analysis.Laryngoscope126(6):1411–9
11.
Zurück zum Zitat Kaur R, Mittal N, Kakkar M, Aggarwal AK, Mathur MD (2000) Otomycosis: a clinicomycologic study. ENT J 79:606–609 Kaur R, Mittal N, Kakkar M, Aggarwal AK, Mathur MD (2000) Otomycosis: a clinicomycologic study. ENT J 79:606–609
12.
Zurück zum Zitat Mgbe R, Umana A, Adekanye A, Offiong M (Jan.2010) Otomycosis-A Management Challenge in Calabar, South-South Nigeria.The Internet Journal of Third World Medicine9 (2) Mgbe R, Umana A, Adekanye A, Offiong M (Jan.2010) Otomycosis-A Management Challenge in Calabar, South-South Nigeria.The Internet Journal of Third World Medicine9 (2)
13.
Zurück zum Zitat Ozcan KM, Ozcan M, Karaarslan A, Karaarslan F (2003) Otomycosis in Turkey: predisposing factors, aetiology and therapy. J Laryngol Otol 117(01):39–42CrossRefPubMed Ozcan KM, Ozcan M, Karaarslan A, Karaarslan F (2003) Otomycosis in Turkey: predisposing factors, aetiology and therapy. J Laryngol Otol 117(01):39–42CrossRefPubMed
14.
Zurück zum Zitat Kiakojuri K, Rajabnia R, Mahdavi Omran S, Pournajaf A, Karami M, Taghizadeh Armaki M (Dec.2019) Role of clotrimazole in prevention of recurrent otomycosis.BioMed research international26;2019. Kiakojuri K, Rajabnia R, Mahdavi Omran S, Pournajaf A, Karami M, Taghizadeh Armaki M (Dec.2019) Role of clotrimazole in prevention of recurrent otomycosis.BioMed research international26;2019.
15.
Zurück zum Zitat Gharaghani M, Seifi Z, Zarei Mahmoudabadi A (2015) Otomycosis in Iran: a review. Mycopathologia. 1;179 (5–6):415 – 24 Gharaghani M, Seifi Z, Zarei Mahmoudabadi A (2015) Otomycosis in Iran: a review. Mycopathologia. 1;179 (5–6):415 – 24
16.
Zurück zum Zitat Anwar K, Gohar MS (May 2014) Otomycosis; clinical features, predisposing factors and treatment implications. Pakistan J Med Sci 30(3):564 Anwar K, Gohar MS (May 2014) Otomycosis; clinical features, predisposing factors and treatment implications. Pakistan J Med Sci 30(3):564
17.
Zurück zum Zitat Hsu DZ, Chen YW, Chu PY, Periasamy S, Liu MY (2013) Protective effect of 3, 4-methylenedioxyphenol (sesamol) on stress-related mucosal disease in rats.BioMed research international1;2013. Hsu DZ, Chen YW, Chu PY, Periasamy S, Liu MY (2013) Protective effect of 3, 4-methylenedioxyphenol (sesamol) on stress-related mucosal disease in rats.BioMed research international1;2013.
18.
Zurück zum Zitat Yehia MM, Habib A, Shehab HM NM (1990) Otomycosis: A common problem in North Iraq. J Laryngology Otology 104:380–389CrossRef Yehia MM, Habib A, Shehab HM NM (1990) Otomycosis: A common problem in North Iraq. J Laryngology Otology 104:380–389CrossRef
19.
Zurück zum Zitat Pradhan B, Tuladhar NR, Amatya RM (eds) (2003) Prevalence of otomycosis in outpatient department of otolaryngology in Tribhuvan University Teaching Hospital, Kathmandu, Nepal. Annalas of Otology, Rhinology& Laryngology 112(4): 384–387 Pradhan B, Tuladhar NR, Amatya RM (eds) (2003) Prevalence of otomycosis in outpatient department of otolaryngology in Tribhuvan University Teaching Hospital, Kathmandu, Nepal. Annalas of Otology, Rhinology& Laryngology 112(4): 384–387
20.
Zurück zum Zitat Aneja KR, Sharma C, Joshi R (2010) Fungal infection of the ear: a common problem in the north eastern part of Haryana. International journal of pediatric otorhinolaryngology 1;74(6):604-7 Aneja KR, Sharma C, Joshi R (2010) Fungal infection of the ear: a common problem in the north eastern part of Haryana. International journal of pediatric otorhinolaryngology 1;74(6):604-7
21.
Zurück zum Zitat Fasunla J, Ibekwe T, Onakoya P (eds) (2008) (Jan Otomycosis in western Nigeria. Mycoses 51(1):67–70 Fasunla J, Ibekwe T, Onakoya P (eds) (2008) (Jan Otomycosis in western Nigeria. Mycoses 51(1):67–70
22.
Zurück zum Zitat Mohanty JC, Mohanty SK, Sahoo RC, Ghosh SK, Chayani N, Mallick B, Kar AK (1995) Clinico-microbial profile of otomycosis in Berhampur. Indian J Otology 5(2):81–83 Mohanty JC, Mohanty SK, Sahoo RC, Ghosh SK, Chayani N, Mallick B, Kar AK (1995) Clinico-microbial profile of otomycosis in Berhampur. Indian J Otology 5(2):81–83
23.
Zurück zum Zitat Nwabuisi C, Ologe FE (eds) (2001) The fungal profile of otomycosis patients in Ilorin, Nigeria. Nigerian journal of medicine: journal of the National Association of Resident Doctors of Nigeria 1;10(3):124-6 Nwabuisi C, Ologe FE (eds) (2001) The fungal profile of otomycosis patients in Ilorin, Nigeria. Nigerian journal of medicine: journal of the National Association of Resident Doctors of Nigeria 1;10(3):124-6
24.
Zurück zum Zitat Kombila M, Gomez de Diaz M, De Bievre C, Crepet G, Debrie JC, Belembaogo E, Richard-Lenoble D (Jan.1989) Fungal otitis in Libreville. Study of 83 cases. Bulletin de la Société de pathologie exotique et de ses filiales 1;82(2):201-7 Kombila M, Gomez de Diaz M, De Bievre C, Crepet G, Debrie JC, Belembaogo E, Richard-Lenoble D (Jan.1989) Fungal otitis in Libreville. Study of 83 cases. Bulletin de la Société de pathologie exotique et de ses filiales 1;82(2):201-7
25.
Zurück zum Zitat Jimenez-Garcia L, Celis-Aguilar E, Díaz-Pavón G, Muñoz Estrada V, Castro-Urquizo Á, Hernández-Castillo N, Amaro-Flores E (Jul.2020) Efficacy of topical clotrimazole vs. topical tolnaftate in the treatment of otomycosis. A randomized controlled clinical trial.Brazilian journal of otorhinolaryngology13;86:300–7 Jimenez-Garcia L, Celis-Aguilar E, Díaz-Pavón G, Muñoz Estrada V, Castro-Urquizo Á, Hernández-Castillo N, Amaro-Flores E (Jul.2020) Efficacy of topical clotrimazole vs. topical tolnaftate in the treatment of otomycosis. A randomized controlled clinical trial.Brazilian journal of otorhinolaryngology13;86:300–7
26.
Zurück zum Zitat Bineshian F, Irajian GR, Fredonian M (2006) A study on the frequency of fungal agents in otitis externa in Semnan. Iran J Pathol 1(4):141–144 Bineshian F, Irajian GR, Fredonian M (2006) A study on the frequency of fungal agents in otitis externa in Semnan. Iran J Pathol 1(4):141–144
27.
Zurück zum Zitat Gutierrez PH, Álvarez S, Sanudo J, Garcia EGC, Sanchez LMGC, Valdezate CR (2005) Presumed diagnosis: Otomycosis. A study of 451 patients. Acta Otorrinolaringol Esp 56:181–186CrossRef Gutierrez PH, Álvarez S, Sanudo J, Garcia EGC, Sanchez LMGC, Valdezate CR (2005) Presumed diagnosis: Otomycosis. A study of 451 patients. Acta Otorrinolaringol Esp 56:181–186CrossRef
28.
Zurück zum Zitat Adegbiji WA, Alabi BS, Olajuyin OA, Nwawolo CC (eds) (2014) Earwax impaction: Symptoms, predisposing factors and perception among Nigerians. Journal of family medicine and primary care 3(4):379 Adegbiji WA, Alabi BS, Olajuyin OA, Nwawolo CC (eds) (2014) Earwax impaction: Symptoms, predisposing factors and perception among Nigerians. Journal of family medicine and primary care 3(4):379
29.
Zurück zum Zitat Czechowicz JA, Messner AH, Alarcon-Matutti E, Alarcon J, Quinones-Calderon G, Montano S, Zunt JR (Feb. 2010) Hearing impairment and poverty: the epidemiology of ear disease in Peruvian schoolchildren. Otolaryngology—Head and Neck Surgery 142(2):272–277 Czechowicz JA, Messner AH, Alarcon-Matutti E, Alarcon J, Quinones-Calderon G, Montano S, Zunt JR (Feb. 2010) Hearing impairment and poverty: the epidemiology of ear disease in Peruvian schoolchildren. Otolaryngology—Head and Neck Surgery 142(2):272–277
30.
Zurück zum Zitat Anwar K, Ghoar MS (2014) Otomycosis Clinical features, predisposing factors and treatment implications”. Pak Med Sci 30:564–567 Anwar K, Ghoar MS (2014) Otomycosis Clinical features, predisposing factors and treatment implications”. Pak Med Sci 30:564–567
31.
Zurück zum Zitat Nowrozi H, Arabi FD, Mehraban HG, Tavakoli A, Ghooshchi G (eds) (2014) Mycological and clinical study of otomycosis in Tehran, Iran. Bull Environ Pharmacol Life Sci. 3(2):29–31 Nowrozi H, Arabi FD, Mehraban HG, Tavakoli A, Ghooshchi G (eds) (2014) Mycological and clinical study of otomycosis in Tehran, Iran. Bull Environ Pharmacol Life Sci. 3(2):29–31
32.
Zurück zum Zitat Prasad SC, Kotigadde S, Shekhar M, Thada ND, Prabhu P, D’Souza T, Prasad KC (Apr.2014) Primary otomycosis in the Indian subcontinent: predisposing factors, microbiology, and classification.International journal of microbiology1–9 Prasad SC, Kotigadde S, Shekhar M, Thada ND, Prabhu P, D’Souza T, Prasad KC (Apr.2014) Primary otomycosis in the Indian subcontinent: predisposing factors, microbiology, and classification.International journal of microbiology1–9
33.
Zurück zum Zitat Beany GP, Broughton A, Sept (1967) Tropical otomycosis. J Laryngology Otology 81(9):987–997CrossRef Beany GP, Broughton A, Sept (1967) Tropical otomycosis. J Laryngology Otology 81(9):987–997CrossRef
34.
Zurück zum Zitat Malik AA, Malik SN, Aslam MA, Rasheed D (2012) Comparative efficacy of topical clotrimazole and 3% salicylic acid in otomycosis. Rawal Med J 13(37):46–49 Malik AA, Malik SN, Aslam MA, Rasheed D (2012) Comparative efficacy of topical clotrimazole and 3% salicylic acid in otomycosis. Rawal Med J 13(37):46–49
35.
Zurück zum Zitat Ologe FE, Nwabuisi C (eds) (2002) Treatment outcome of otomycosis in Ilorin, Nigeria. West African Journal of Medicine 1; 21(1):34–6 Ologe FE, Nwabuisi C (eds) (2002) Treatment outcome of otomycosis in Ilorin, Nigeria. West African Journal of Medicine 1; 21(1):34–6
36.
Zurück zum Zitat Jadhav VJ, Pal M, Mishra GS (Dec.2003) Etiological significance of Candida albicans in otitis externa.Mycopathologia156(4):313–5 Jadhav VJ, Pal M, Mishra GS (Dec.2003) Etiological significance of Candida albicans in otitis externa.Mycopathologia156(4):313–5
37.
Zurück zum Zitat Ahmed Z, Hafeez A, Zahid T, Jawaid MA, Matiullah S, Marfani MS (2010) Otomycosis: Clinical presentation and management. Pak J Otolaryngol 26:78–80 Ahmed Z, Hafeez A, Zahid T, Jawaid MA, Matiullah S, Marfani MS (2010) Otomycosis: Clinical presentation and management. Pak J Otolaryngol 26:78–80
38.
Zurück zum Zitat Munguia R, Daniel SJ (2008) Ototopical antifungals and otomycosis: A review. Int J Pediatr Otorhinolaryngol 72:453–459CrossRefPubMed Munguia R, Daniel SJ (2008) Ototopical antifungals and otomycosis: A review. Int J Pediatr Otorhinolaryngol 72:453–459CrossRefPubMed
39.
Zurück zum Zitat Khan F, Muhammad R, Khan MR, Rehman F, Iqbal J, Khan M, Ullah G, Jan-Jun (2013) Efficacy of topical clotrimazole in treatment of otomycosis. J Ayub Med Coll Abbottabad 25(1–2):78–80PubMed Khan F, Muhammad R, Khan MR, Rehman F, Iqbal J, Khan M, Ullah G, Jan-Jun (2013) Efficacy of topical clotrimazole in treatment of otomycosis. J Ayub Med Coll Abbottabad 25(1–2):78–80PubMed
40.
Zurück zum Zitat Vega-Nava CT, Borrego-Montoya CR, Vásquez-del Mercado E, Vega-Sánchez DC, Arenas R (Aug.2015)Otitis externa de origen fúngico. Estudio de 36 pacientes en un hospital general. InAnales de Otorrinolaringología Mexicana 28 (Vol. 60, No. 3, pp. 175–178) Vega-Nava CT, Borrego-Montoya CR, Vásquez-del Mercado E, Vega-Sánchez DC, Arenas R (Aug.2015)Otitis externa de origen fúngico. Estudio de 36 pacientes en un hospital general. InAnales de Otorrinolaringología Mexicana 28 (Vol. 60, No. 3, pp. 175–178)
41.
Zurück zum Zitat Dundar R, İynen İ (2019) Single Dose Topical Application of Clotrimazole for the Treatment of Otomycosis: Is this Enough? J Audiol Otology 23(1):15–19CrossRef Dundar R, İynen İ (2019) Single Dose Topical Application of Clotrimazole for the Treatment of Otomycosis: Is this Enough? J Audiol Otology 23(1):15–19CrossRef
42.
Zurück zum Zitat Jackman A, Ward R, April M, Bent J (June 2005) Topical antibiotic induced otomycosis. Int J Pediatr Otorhinolaryngol 1(6):857–860 Jackman A, Ward R, April M, Bent J (June 2005) Topical antibiotic induced otomycosis. Int J Pediatr Otorhinolaryngol 1(6):857–860
43.
Zurück zum Zitat Paulose KO, Al Khalifa S, Shenoy P, Sharma RK (Jan1989)Mycotic infection of the ear (otomycosis): a prospective study.The Journal of Laryngology & otology103:30–5 Paulose KO, Al Khalifa S, Shenoy P, Sharma RK (Jan1989)Mycotic infection of the ear (otomycosis): a prospective study.The Journal of Laryngology & otology103:30–5
44.
Zurück zum Zitat Jia X, Liang Q, Chi F, Cao W (Sep.2012) Otomycosis in Shanghai: aetiology, clinical features and therapy.Mycoses55(5):404–9 Jia X, Liang Q, Chi F, Cao W (Sep.2012) Otomycosis in Shanghai: aetiology, clinical features and therapy.Mycoses55(5):404–9
45.
Zurück zum Zitat Anwar K, Gohar MS (May 2014) Otomycosis; clinical features, predisposing factors and treatment implications. Pakistan J Med Sci 30(3):566 Anwar K, Gohar MS (May 2014) Otomycosis; clinical features, predisposing factors and treatment implications. Pakistan J Med Sci 30(3):566
46.
Zurück zum Zitat Nemati S, Hassanzadeh R, Jahromi SK, Abadi AD (May 2014) Otomycosis in the north of Iran: common pathogens and resistance to antifungal agents. Eur Arch Otorhinolaryngol 271(5):953–957 Nemati S, Hassanzadeh R, Jahromi SK, Abadi AD (May 2014) Otomycosis in the north of Iran: common pathogens and resistance to antifungal agents. Eur Arch Otorhinolaryngol 271(5):953–957
47.
Zurück zum Zitat Naqi S, Bashir F, Khan A, Mahmud T (2014) Old is gold Topical clotimazole remains an effective treatment of otomycosis. Proceedings Shaikh Zayed Postgraduate Medical Institute 28(1):39–43 Naqi S, Bashir F, Khan A, Mahmud T (2014) Old is gold Topical clotimazole remains an effective treatment of otomycosis. Proceedings Shaikh Zayed Postgraduate Medical Institute 28(1):39–43
48.
Zurück zum Zitat Kazemi A, Majidinia M, Jaafari A, Mousavi SA, Mahmoudabadi AZ, Alikhah H (Sept.2015)Etiologic agents of otomycosis in the North-Western area of Iran.Jundishapur journal of microbiology8 (9). Kazemi A, Majidinia M, Jaafari A, Mousavi SA, Mahmoudabadi AZ, Alikhah H (Sept.2015)Etiologic agents of otomycosis in the North-Western area of Iran.Jundishapur journal of microbiology8 (9).
Metadaten
Titel
Single Topical Application of 1% Clotrimazole Cream in Otomycosis
verfasst von
Reshma P. Chavan
Shivraj M. Ingole
Gajanan S. Kanchewad Resident
Publikationsdatum
08.12.2022
Verlag
Springer India
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe Sonderheft 1/2023
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-022-03206-x

Weitere Artikel der Sonderheft 1/2023

Indian Journal of Otolaryngology and Head & Neck Surgery 1/2023 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.